LEADER 04115nam  2200589 a 450 
001 9910816335403321
005 20230721021423.0
010   $a1-282-07418-0
010   $a9786612074189
010   $a81-224-2638-7
035   $a(CKB)1000000000750493
035   $a(EBL)3017375
035   $a(SSID)ssj0000672293
035   $a(PQKBManifestationID)11459786
035   $a(PQKBTitleCode)TC0000672293
035   $a(PQKBWorkID)10634514
035   $a(PQKB)11502264
035   $a(MiAaPQ)EBC3017375
035   $a(Au-PeEL)EBL3017375
035   $a(CaPaEBR)ebr10318746
035   $a(CaONFJC)MIL207418
035   $a(OCoLC)923652138
035   $a(EXLCZ)991000000000750493
100   $a20091006d2007      uy             0
101 0 $aeng
135   $aurcn|||||||||
181   $ctxt
182   $cc
183   $acr
200 10$aEconomics of biotechnology$b[electronic resource] /$fT.V.S. Ramamohan Rao
210   $aNew Delhi $cNew Age International (P) Ltd., Publishers$dc2007
215   $a1 online resource (198 p.)
300   $aDescription based upon print version of record.
311   $a81-224-2003-6 
320   $aIncludes bibliographical references and index.
327   $a""Cover ""; ""Preface ""; ""Contents ""; ""Chapter 1 Introduction ""; ""1.1 Changing Technology ""; ""1.2 Modern Biotechnology ""; ""1.3 Organizational Issues ""; ""1.4 Patents and IPR's ""; ""1.5 Market Structure ""; ""1.6 Ethical and Environmental Concerns ""; ""1.7 Government Policy ""; ""1.8 Looking Ahead ""; ""Chapter 2 Organizational Structure ""; ""2.1 The Scope ""; ""2.2 Knowledge Intensity ""; ""2.3 Biotechnology Knowledge ""; ""2.4 Network Organization ""; ""2.5 Nature of Contracts ""; ""2.6 Sharing Fixed Costs ""; ""2.7 Economic Consequences ""; ""2.8 Other Aspects ""
327   $a""Chapter 3 IPRs and Patents """"3.1 Why Protection? ""; ""3.2 Patents as Protection ""; ""3.3 Biotechnology Patents ""; ""3.4 IPR Agreements ""; ""3.5 TRIPS Agreement  ""; ""3.6 Consequences of Protection ""; ""3.7 Issues of Concern ""; ""3.8 Modifications to Patent Regime ""; ""Chapter 4 Investment and Financing ""; ""4.1 The Issues ""; ""4.2 Role of Public Investment ""; ""4.3 R&D in Scientific Knowledge ""; ""4.4 Risks of R&D ""; ""4.5 Complementary R&D ""; ""4.6 Agricultural Extension Services ""; ""4.7 Bioprocessing ""; ""4.8 Physical Capital ""; ""4.9 Financing Constraints ""
327   $a""4.10 Further Considerations """"Chapter 5 Demand, Cost and Productivity ""; ""5.1 The Background ""; ""5.2 Patterns of Demand ""; ""5.3 Productivity ""; ""5.4 Variable Costs ""; ""5.5 Welfare Effects ""; ""5.6 Summing Up ""; ""Chapter 6 Market Structure and Pricing ""; ""6.1 Nature of Markets ""; ""6.2 Defining Market Concentration  ""; ""6.3 Sources of Concentration ""; ""6.4 Monopoly Power and Pricing ""; ""6.5 Differential Pricing ""; ""6.6 Dynamic Pricing ""; ""6.7 In Retrospect ""; ""Chapter 7 Ethics and Environment ""; ""7.1 Issues at Stake ""; ""7.2 Ethical Issues ""
327   $a""7.3 Environmental Issues """"7.4 Ethical Issues in Agricultural Biotechnology ""; ""7.5 Ethical Issues in Drug Development ""; ""7.6 Environmental Issues ""; ""7.7 International Conventions ""; ""7.8 Lessons and Control ""; ""Chapter 8 Government Policy ""; ""8.1 An Overview ""; ""8.2 Scientific R&D ""; ""8.3 Scientist vs. NBF Contract ""; ""Chapter 9 Conclusion ""; ""9.1 The Technology ""; ""9.2 Organizational Aspects ""; ""9.3 Product Profiles and Markets ""; ""9.4 Negative effects ""; ""9.5 Steady State ""; ""Appendices ""; ""Appendix 1 Technical Terms ""
327   $a""Appendix 2 Economic Concepts """"Appendix 3 Mathematical Background ""; ""References ""; ""Index ""
606   $aBiotechnology$xEconomic aspects
606   $aBiotechnology industries
615  0$aBiotechnology$xEconomic aspects.
615  0$aBiotechnology industries.
700   $aRamamohan Rao$b T. V. S$01129433
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910816335403321
996   $aEconomics of biotechnology$93934063
997   $aUNINA